Rakuten Medical
Rakuten Medical is a United States-based biotechnology company running 3 late-stage cancer trials in head and neck squamous cell carcinoma and cutaneous squamous cell carcinoma.
Overview
Rakuten Medical, based in San Diego, the United States, is a biotechnology company. Rakuten Medical is a biotechnology company creating and bringing to market drugs and devices to treat cancers based on its Alluminox platform of photoimmunotherapy. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials (2 in phase 3) in head and neck squamous cell carcinoma and cutaneous squamous cell carcinoma. The largest, NCT06699212 (A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases), plans to enrol 412 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyAveta Biomics
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyQBiotics
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyAP Biosciences
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyTiumBio
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyEpicentRx
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyScancell
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyVyriad
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyNeonc Technologies
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.